Aviso Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$915K Buy
2,601
+42
+2% +$15K 0.41% 54
2025
Q4
$838K Buy
2,559
+257
+11% +$81.5K 0.35% 67
2025
Q3
$650K Buy
2,302
+158
+7% +$45.8K 0.28% 78
2025
Q2
$599K Sell
2,144
-12
-0.6% -$3.4K 0.28% 82
2025
Q1
$672K Sell
2,156
-110
-5% -$32.5K 0.36% 74
2024
Q4
$590K Buy
2,266
+243
+12% +$72.1K 0.3% 79
2024
Q3
$652K Sell
2,023
-990
-33% -$324K 0.35% 77
2024
Q2
$941K Buy
3,013
+1,185
+65% +$348K 0.56% 45
2024
Q1
$520K Buy
1,828
+259
+17% +$75.8K 0.33% 81
2023
Q4
$452K Buy
+1,569
New +$428K 0.33% 77

Other funds holding AMGN

Aviso Wealth Management's AMGN Position: Q1 2026 in Review

Aviso Wealth Management increased its Amgen (AMGN) stake by 1.6% in Q1 2026, buying an estimated $15K and bringing the position to 2,601 shares worth $915K. The position accounts for 0.41% of the portfolio, ranked #54.

Aviso Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $941K in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Aviso Wealth Management held 2,601 shares of Amgen worth $915K as of Q1 2026.
  • Aviso Wealth Management bought 42 Amgen shares in Q1 2026, an estimated $15K.
  • Amgen made up 0.41% of Aviso Wealth Management's portfolio in Q1 2026, its #54 holding.
  • Aviso Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Aviso Wealth Management's Amgen position peaked at $941K in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aviso Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.